Imaging with radiolabeled TRM-1 in patients with solid malignancies who are treated with gemcitabine, cisplatin and TRM-1.

Trial Profile

Imaging with radiolabeled TRM-1 in patients with solid malignancies who are treated with gemcitabine, cisplatin and TRM-1.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 10 Dec 2009

At a glance

  • Drugs Cisplatin; Gemcitabine; Mapatumumab
  • Indications Solid tumours
  • Focus Adverse reactions; Pharmacokinetics
  • Acronyms TRM-scan
  • Most Recent Events

    • 10 Dec 2009 Planned end date (1 Mar 2010) added as reported by Netherlands Trial Register.
    • 23 Nov 2009 Planned number of patients (10) and planned initiation date (22 Nov 2007) added as reported by Netherlands Trial Register.
    • 23 Nov 2009 Additional lead trial centre (University Medical Center Groningen) identified as reported by Netherlands Trial Register.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top